“…TCC is able to bioaccumulate into the human tissues, for instance, maternal and umbilical cord sera, urine, toe and fingernails, as well as hypothalamus and white matter in the human brain, threatening the safety of human (Pycke et al, 2014;Van Der Meer et al, 2017;Wei et al, 2017). TCC is a novel endocrine disruptor (Chung, Genco, Megrelis, & Ruderman, 2011) and also exacerbates pathophysiological conditions of the central nervous system (CNS), including traumatic injury, stroke, neurodegenerative diseases, autoimmune inflammation (Lee & McEwen, 2001;Wise, 2002 development (Du, Sun, et al, 2018). Another in vivo study using rat hippocampal neurons exposed to PBDE-209 showed the increased apoptosis with improved P38 MAPK level and oxidative stress besides global DNA hypomethylation (J. Chen, Liufu, Sun, Sun, & Chen, 2010).…”